|FOR IMMEDIATE RELEASE
September 16, 2021
Health Care Voices Founder Laura Packard Slams Pharma 3 Opposition to Drug Pricing Proposal as Votes Threaten to Dismantle Build Back Better Prescription-Drug Provision
DENVER — Today, following news that Representatives Scott Peters (CA-52), Kurt Schrader (OR-5) and Kathleen Rice (NY-4) oppose Build Back Better’s drug pricing proposal, Health Care Voices Founder Laura Packard released a statement on the peril of opposing the resoundingly popular proposal.
Americans currently face the highest prescription drug prices in the world. Recent polling shows that taking action to lower the costs we pay is overwhelmingly popular across the board with people of all parties, and in all parts of the country, including their legislative districts. Their votes against this provision mean the entire Build Back Better bill is potentially at risk, as reducing budgetary costs by allowing Medicare to negotiate drug prices is a key way the bill will be funded.
“Over the years, Representatives Peters, Kurt and Rice have raked in more than $1.6 million in campaign funding from Big Pharma donors and health products industries.”
“Americans pay more than any other country for our medications. This proposal would finally do something about that, and ensure that Americans do not have to go without life-saving medication any more.”
“I urge every American to contact their legislators and demand action to finally lower the cost of prescription drugs that we pay. It’s time for all elected officials to show where they stand: with the American people or with Big Pharma.”
Laura Packard is the founder of Health Care Voices and a stage IV cancer survivor. The Affordable Care Act saved her life. She just returned from a national coast-to-coast bus tour with Protect Our Care. If you’re interested in connecting with Laura to discuss the danger opposition to Build Back Better’s prescription-drug pricing proposal poses to every American and her continued advocacy for affordable care, please reach out to email@example.com.